Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Does addition of N-acetyl cysteine, as an adjunct to beta-blocker therapy, decrease the incidence of postcoronary artery bypass atrial fibrillation?

Jabbour, Katarzyna, PharmD, BCPS; Kamath Mulki, Ashwini, MD; Keister, Drew M., MD; Motley, Robert J., MD, MHCDS

doi: 10.1097/EBP.0000000000000041
HELPDESK ANSWERS

Lehigh Valley Health Network FMR, Allentown, PA

The authors declare no conflict of interests.

© Copyright 2018 Family Physicians Inquiries Network, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website